Image For Activity Cover
Controversies in Severe Aortic Stenosis
How to Register
  1. To register, press the "Login or Register" button.
  2. Sign in with your username and password. If you don't have an account, click “Set Up Your Login.”
  3. Once registered, you will see a screen where you can add the webinar to your calendar.
All registrants receive access to the webinar recording and automatic webinar reminders.
Tuesday, September 14, 2021
Eastern Time 7 - 8:15 pm
Central Time 6 - 7:15 pm
Mountain Time 5 - 6:15 pm
Pacific Time 4 - 5:15 pm
TAVR has rapidly expanded to include a broader population with each randomized trial publication, albeit with a focus on transfemoral access. At times the trial data has moved faster than our ability to understand how to apply all options to both our youngest patients and those with high risk features for TAVR (i.e. borderline transfemoral access, small annuli). This webinar will raise important state-of-the-art controversies in the application of aortic valve replacement. The learner will identify new aspects of the therapy to consider when discussing choices with their patients in real-world clinical practice, and to assist in shared decision making.
Agenda and Invited Faculty
Moderator: James B. Hermiller, MD, MSCAI
Q&A Moderator: Melissa Levack, MD
Panelists: Bina Ahmed, MD; Aaron Horne, MD; Tom Nguyen, MD

• Patient Selection and Procedural Planning for Alternate Access, Jay S. Giri, MD, FSCAI
• Preparing for Common Complications: Small Iliofemorals and Low Coronary Height, James M. McCabe, MD, FSCAI
• TAVR in the 65-75 Year Old: How Do You Choose?, Kimberly A. Skelding, MD, FSCAI
• Not All Low Risk Surgical Patients are Ideal for TAVR First: Small Annuli, Adnan K. Chhatriwalla, MD, FSCAI
• Controversy: Young People With Bicuspid Disease Deserve a Choice, Wah Wah Htun, MD, FSCAI
Learning Objectives
After this webinar, participants will be able to:
  1. Review data and technique on optimizing arterial transfemoral (TF) access and plan for TF bailout.
  2. Demonstrate difficult anatomy as interpreted by CT in iliofemorals and review contrast saving techniques to review iliofemoral anatomy.
  3. Discuss data on valve durability.
  4. Describe a case-scenario in which TAVR first is controversial but ultimately beneficial for a young patient.
  5. Compare the benefits and harms of percutaneous interventions with elderly patient at high-risk for TAVR. 
Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

© 2021-2022 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Availability: Registration Required
Expires on 04/01/2022
Location: Online Meeting
Date / Time: Sep 14, 2021 7:00 PM - 8:15 PM EST
Cost: FREE
Credit Offered: 1.25 CME Credits
1.25 ABIM-MOC Points
1.25 Participation Credits
Powered By